MR Imaging Findings in a Large Population of Autoimmune Encephalitis

References

1. 1.↵
   1. Ball C,
   2. Fisicaro R,
   3. Morris L, et al

   . Brain on fire: an imaging-based review of autoimmune encephalitis. Clin Imaging 2022;84:1–30 doi:10.1016/j.clinimag.2021.12.011 pmid:35101768

   CrossRefPubMed
2. 2.↵
   1. Kelley BP,
   2. Patel SC,
   3. Marin HL, et al

   . Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis. AJNR Am J Neuroradiol 2017;38:1070–78 doi:10.3174/ajnr.A5086 pmid:28183838

   Abstract/FREE Full Text
3. 3.↵
   1. Glaser CA,
   2. Gilliam S,
   3. Schnurr D, et al

   ; California Encephalitis Project, 1998-2000. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis 2003;36:731–42 doi:10.1086/367841 pmid:12627357

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Theroux LM,
   2. Goodkin HP,
   3. Heinan KC, et al

   . Extreme delta brush and distinctive imaging in a pediatric patient with autoimmune GFAP astrocytopathy. Mult Scler Relat Disord 2018;26:121–23 doi:10.1016/j.msard.2018.09.015 pmid:30245384

   CrossRefPubMed
5. 5.↵
   1. Abboud H,
   2. Probasco JC,
   3. Irani S, et al

   ; Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 2021;92:757–68 doi:10.1136/jnnp-2020-325300 pmid:33649022

   Abstract/FREE Full Text
6. 6.↵
   1. Budhram A,
   2. Leung A,
   3. Nicolle MW, et al

   . Diagnosing autoimmune limbic encephalitis. CMAJ 2019;191:E529–34 doi:10.1503/cmaj.181548 pmid:31085562

   FREE Full Text
7. 7.↵
   1. Saraya AW,
   2. Worachotsueptrakun K,
   3. Vutipongsatorn K, et al

   . Differences and diversity of autoimmune encephalitis in 77 cases from a single tertiary care center. BMC Neurol 2019;19:273 doi:10.1186/s12883-019-1501-5 pmid:31694559

   CrossRefPubMed
8. 8.↵
   1. Si Z,
   2. Wang A,
   3. Liu J, et al

   . Typical clinical and imaging manifestations of encephalitis with anti-γ-aminobutyric acid B receptor antibodies: clinical experience and a literature review. Neurol Sci 2019;40:769–77 doi:10.1007/s10072-018-3679-5 pmid:30671737

   CrossRefPubMed
9. 9.↵
   1. Kotsenas AL,
   2. Watson RE,
   3. Pittock SJ, et al

   . MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. AJNR Am J Neuroradiol 2014;35:84–89 doi:10.3174/ajnr.A3633 pmid:23868165

   Abstract/FREE Full Text
10. 10.↵
    1. Wu H,
    2. Yu H,
    3. Joseph J, et al

    . Neuroimaging and CSF findings in patients with autoimmune encephalitis: a report of eight cases in a single academic center. Neurol Int 2022;14:176–85 doi:10.3390/neurolint14010014 pmid:35225884

    CrossRefPubMed
11. 11.↵
    1. Lin J,
    2. Lu L,
    3. Li J

    . Typical linear radial periventricular enhancement in a patient with glial fibrillary acidic protein (GFAP) astrocytopathy. Neurol Sci 2022;43:2895–97 doi:10.1007/s10072-022-05937-9 pmid:35146565

    CrossRefPubMed
12. 12.↵
    1. Zouras S,
    2. Stephens JW,
    3. Abburu SR, et al

    . Anti-LGI1 encephalitis causing faciobrachial dystonic seizures. BMJ Case Rep 2017;2017:bcr-2017-221089 doi:10.1136/bcr-2017-221089 pmid:29103007

    CrossRefPubMed
13. 13.↵
    1. Vogrig A,
    2. Joubert B,
    3. Maureille A, et al

    . Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome. J Neurol 2019;266:398–410 doi:10.1007/s00415-018-9143-x pmid:30498914

    CrossRefPubMed
14. 14.↵
    1. Compta Y,
    2. Iranzo A,
    3. Santamaría J, et al

    . REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis. Sleep 2007;30:767–69 doi:10.1093/sleep/30.6.767 pmid:17580598

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Saul RF

    . Neuro-ophthalmology and the anti-GQ1b antibody syndromes. Curr Neurol Neurosci Rep 2009; 379–83 doi:10.1007/s11910-009-0055-0 pmid:19664367

    CrossRefPubMed
16. 16.↵
    1. Bacchi S,
    2. Franke K,
    3. Wewegama D, et al

    . Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: a systematic review. J Clin Neurosci 2018;52:54–59 doi:10.1016/j.jocn.2018.03.026 pmid:29605275

    CrossRefPubMed
17. 17.↵
    1. Ha J,
    2. Na BS,
    3. Ahn JH, et al

    . Anti-CV2/CRMP5 paraneoplastic chorea effectively managed with intravenous amantadine. Tremor Other Hyperkinet Mov (N Y) 2019;9 doi:10.7916/tohm.v0.701 pmid:31656691

    CrossRefPubMed
18. 18.↵
    1. Wu X,
    2. Wang H,
    3. Xu G, et al

    . Anti-CV2 autoimmune encephalitis with Parkinson-like symptoms and bilateral leukoencephalopathy: a case report. Front Neurol 2019;10:1064 doi:10.3389/fneur.2019.01064 pmid:31649611

    CrossRefPubMed
19. 19.↵
    1. Gomez-Figueroa E,
    2. Garcia-Estrada C,
    3. Paredes-Aragon E, et al

    . Brain MRI volumetric changes in the follow-up of patients with anti-NMDAr encephalitis. Clin Neurol Neurosurg 2021;209:106908 doi:10.1016/j.clineuro.2021.106908 pmid:34488009

    CrossRefPubMed
20. 20.↵
    1. Lee B,
    2. Lee JH,
    3. Lim YM, et al

    . High-resolution MR imaging of cranial neuropathy in patients with anti-GQ1b antibody syndrome. J Neurol Sci 2021;423:117380 doi:10.1016/j.jns.2021.117380 pmid:33677393

    CrossRefPubMed
21. 21.↵
    1. Renard D,
    2. Taieb G,
    3. Briere C, et al

    . Mild encephalitis/encephalopathy with a reversible splenial, white matter, putaminal, and thalamic lesions following anti-Yo rhombencephalitis. Acta Neurol Belg 2012;112:405–07 doi:10.1007/s13760-012-0080-7 pmid:22577040

    CrossRefPubMed
22. 22.↵
    1. Li W,
    2. Wu S,
    3. Meng Q, et al

    . Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study. BMC Neurol 2018;18:1–8 doi:10.1186/s12883-018-1099-z pmid:29980179

    CrossRefPubMed
23. 23.↵
    1. Neo S,
    2. Yeo T,
    3. Chen Z, et al

    . Acute radiological features facilitate diagnosis and prognosis of anti-N-methyl-D-aspartate receptor (NMDAR) and anti-voltage-gated potassium channel (VGKC) encephalitis in adults. J Neurol Sci 2020;419:117216 doi:10.1016/j.jns.2020.117216 pmid:33171389

    CrossRefPubMed
24. 24.↵
    1. Endres D,
    2. Perlov E,
    3. Stich O, et al

    . Case report: low-titre anti-Yo reactivity in a female patient with psychotic syndrome and frontoparieto-cerebellar atrophy. BMC Psychiatry 2015;15:112 doi:10.1186/s12888-015-0486-x pmid:25963777

    CrossRefPubMed
25. 25.↵
    1. Fang B,
    2. McKeon A,
    3. Hinson SR, et al

    . Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol 2016;73:1297–307 doi:10.1001/jamaneurol.2016.2549 pmid:27618707

    CrossRefPubMed
26. 26.↵
    1. Swayne A,
    2. Warren N,
    3. Prain K, et al

    . An Australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation, investigation results, and response to therapy. Front Neurol 2021;12:607773 doi:10.3389/fneur.2021.607773 pmid:33692738

    CrossRefPubMed
27. 27.↵
    1. Gu Y,
    2. Zhong M,
    3. He L, et al

    . Epidemiology of antibody-positive autoimmune encephalitis in Southwest China: a multicenter study. Front Immunol 2019;10:2611 doi:10.3389/fimmu.2019.02611 pmid:31781111

    CrossRefPubMed
28. 28.↵
    1. Wang Y,
    2. Miao A,
    3. Shi Y, et al

    . Influencing electroclinical features and prognostic factors in patients with anti-NMDAR encephalitis: a cohort follow-up study in Chinese patients. Sci Rep 2020;10:10753 doi:10.1038/s41598-020-67485-6 pmid:31694559

    CrossRefPubMed
29. 29.↵
    Stata Statistical Software: Release 16. 2019. https://www.stata.com/stata-news/news35-1/updates-to-stata16/. Accessed May 5, 2022
30. 30.↵
    1. Zrzavy T,
    2. Höftberger R,
    3. Wimmer I, et al

    . Longitudinal CSF findings in autoimmune encephalitis: a monocentric cohort study. Front Immunol 2021;12:646940 doi:10.3389/fimmu.2021.646940 pmid:33828556

    CrossRefPubMed
31. 31.↵
    1. Shao X,
    2. Fan S,
    3. Luo H, et al

    . Brain magnetic resonance imaging characteristics of anti-leucine-rich glioma-inactivated 1 encephalitis and their clinical relevance: a single-center study in China. Front Neurol 2021;11:618109 doi:10.3389/fneur.2020.618109 pmid:33510707

    CrossRefPubMed
32. 32.↵
    1. Vallabhaneni D,
    2. Naveed MA,
    3. Mangla R, et al

    . Perfusion imaging in autoimmune encephalitis. Case Rep Radiol 2018;2018:3538645 doi:10.1155/2018/3538645 pmid:29854534

    CrossRefPubMed
33. 33.↵
    1. Bordonne M,
    2. Chawki MB,
    3. Doyen M, et al

    . Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis. Eur J Nucl Med Mol Imaging 2021;48:3847–58 doi:10.1007/s00259-021-05299-y pmid:33677643

    CrossRefPubMed
34. 34.↵
    1. Yedavalli VS,
    2. Hamam O,
    3. Bahouth M, et al

    . Arterial spin labeling imaging characteristics of anti-leucine-rich glioma-inactivated 1 encephalitis: a qualitative and quantitative analysis. Front Neurol 2022;13:850029 doi:10.3389/fneur.2022.850029 pmid:35979060

    CrossRefPubMed
35. 35.↵
    1. Probasco JC,
    2. Solnes L,
    3. Nalluri A, et al

    . Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 2017;4:e352 doi:10.1212/NXI.0000000000000352 pmid:28567435

    Abstract/FREE Full Text
36. 36.↵
    1. Heine J,
    2. Prüss H,
    3. Bartsch T, et al

    . Imaging of autoimmune encephalitis: relevance for clinical practice and hippocampal function. Neuroscience 2015;309:68–83 doi:10.1016/j.neuroscience.2015.05.037 pmid:26012492

    CrossRefPubMed
37. 37.↵
    1. Dalmau J,
    2. Rosenfeld MR

    . Autoimmune encephalitis update. Neuro Oncol 2014;16:771–78 doi:10.1093/neuonc/nou030 pmid:24637228

    CrossRefPubMed
38. 38.↵
    1. Rees JH

    . Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage. J Neurol Neurosurg Psychiatry.2004;75(Suppl 2):ii43–50 doi:10.1136/jnnp.2004.040378 pmid:15146039

    FREE Full Text
39. 39.↵
    1. Hébert J,
    2. Gros P,
    3. Lapointe S, et al

    . Searching for autoimmune encephalitis: beware of normal CSF. J Neuroimmunol 2020;345:577285 doi:10.1016/j.jneuroim.2020.577285 pmid:32563126

    CrossRefPubMed